Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K
Decreased Body Temperature01:29

Decreased Body Temperature

1.2K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reality check for mHealth sleep apps: bridging the empirical void in digital sleep health.

Sleep·2026
Same author

Letter to the editor: Attrition as a proxy for acceptability in digital CBTi: Conceptual limitations and methodological priorities.

Sleep medicine reviews·2026
Same author

Digital Cognitive Behavioural Therapy for Insomnia Compared to Sleep Health Education in Older Adults With Mild Cognitive Impairment and Insomnia: A Feasibility Randomised Controlled Trial.

Journal of sleep research·2026
Same author

Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial.

Journal of sleep research·2026
Same author

Exploring the Interplay of Sleep Disturbance, Low Back Pain and Health Care Experiences: A Mixed Methods Study.

Behavioral sleep medicine·2025
Same author

The impact of exercise on fat free mass reduction during very low energy diet-induced weight loss in adults with overweight or obesity: A systematic review and meta-analysis.

Obesity research & clinical practice·2025

Related Experiment Video

Updated: Apr 14, 2026

Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

3.0K

Effect of a pharmacologically induced decrease in core temperature in rats resuscitated from cardiac arrest.

Laurence M Katz1, Jonathan E Frank1, Lawrence T Glickman2

  • 1Department of Emergency Medicine, University of North Carolina School of Medicine, United States.

Resuscitation
|April 25, 2015
PubMed
Summary
This summary is machine-generated.

Pharmacologically induced hypothermia using HBN-1 significantly improved survival and neurological outcomes in rats after cardiac arrest. This method offers a practical alternative to physical cooling for post-cardiac arrest care.

Keywords:
Cardiac arrestHypothermiaResuscitation

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.5K
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

3.0K
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.5K
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.5K

Area of Science:

  • Cardiovascular Research
  • Neuroscience
  • Pharmacology

Background:

  • Therapeutic hypothermia is recommended for unconscious cardiac arrest survivors to enhance neurological recovery.
  • Implementation of temperature management is often limited due to practical difficulties.

Purpose of the Study:

  • To assess the effectiveness of pharmacologically induced hypothermia on survival and neurological outcomes in a rat model of cardiac arrest.
  • To compare a novel pharmacological hypothermia agent (HBN-1) with physical cooling methods.

Main Methods:

  • Cardiac arrest was induced in 120 rats; 61 were resuscitated and randomized to normothermia, physical cooling, or pharmacological hypothermia (HBN-1: ethanol, vasopressin, lidocaine).
  • HBN-1 was administered at ambient temperature (20 °C), while physical cooling used iced saline and cooling pads.
  • Neurological outcomes were evaluated using deficit scores and the Morris Water Maze test.

Main Results:

  • HBN-1 achieved target temperature (33.5 °C) significantly faster (85 min) than physical cooling (247 min).
  • Survival rates and neurological deficit scores were significantly improved in the HBN-1 group compared to the normothermic group.
  • HBN-1 demonstrated superior early neurological outcomes compared to physical cooling, though long-term maze performance showed no significant difference.

Conclusions:

  • Pharmacological induction of hypothermia with HBN-1 provides rapid and sustained therapeutic hypothermia.
  • HBN-1 significantly enhances survival and neurological recovery following cardiac arrest in rats.
  • Regulated pharmacological hypothermia presents a viable and practical alternative to physical cooling methods for post-cardiac arrest care.